Clinical Trial: Clonidine as Adjunct Therapy for the Treatment of Neonatal Abstinence Syndrome

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: Efficacy of Clonidine in the Treatment of Neonatal Abstinence Syndrome: A Prospective, Double Blind, Randomized Controlled Trial

Brief Summary: To test the hypothesis that the combination of the tincture of opium (DTO) and clonidine will be more effective in treating infants with neonatal abstinence syndrome (opioid withdrawal) than tincture of opium (DTO) alone.

Detailed Summary:
Sponsor: National Institute on Drug Abuse (NIDA)

Current Primary Outcome: Length of treatment for neonatal abstinence syndrome [ Time Frame: duration of the treatment ]

Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: National Institute on Drug Abuse (NIDA)

Dates:
Date Received: July 31, 2007
Date Started: July 2002
Date Completion:
Last Updated: January 10, 2017
Last Verified: July 2007